Detalles de la búsqueda
1.
Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies.
J Enzyme Inhib Med Chem
; 37(1): 1389-1403, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577416
2.
Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies.
J Enzyme Inhib Med Chem
; 37(1): 2206-2222, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980113
3.
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects.
Molecules
; 27(14)2022 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35889478
4.
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2.
Molecules
; 27(13)2022 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35807326
5.
(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies.
Molecules
; 27(22)2022 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36431818
6.
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies.
Molecules
; 27(19)2022 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36234734
Resultados
1 -
6
de 6
1
Próxima >
>>